These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27824682)

  • 1. Treating schizophrenia during menopause.
    Brzezinski A; Brzezinski-Sinai NA; Seeman MV
    Menopause; 2017 May; 24(5):582-588. PubMed ID: 27824682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women.
    Grigoriadis S; Seeman MV
    Can J Psychiatry; 2002 Jun; 47(5):437-42. PubMed ID: 12085678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for schizophrenia in postmenopausal women.
    González-Rodríguez A; Seeman MV
    Expert Opin Pharmacother; 2018 Jun; 19(8):809-821. PubMed ID: 29676942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic Response Worsens With Postmenopausal Duration in Women With Schizophrenia.
    González-Rodríguez A; Catalán R; Penadés R; Ruiz Cortés V; Torra M; Seeman MV; Bernardo M
    J Clin Psychopharmacol; 2016 Dec; 36(6):580-587. PubMed ID: 27626286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating schizophrenia at the time of menopause.
    Seeman MV
    Maturitas; 2012 Jun; 72(2):117-20. PubMed ID: 22503514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
    Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.
    Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K
    PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
    Utian WH
    Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone therapy might be underutilized in women with early menopause.
    Lindh-Åstrand L; Hoffmann M; Järvstråt L; Fredriksson M; Hammar M; Spetz Holm AC
    Hum Reprod; 2015 Apr; 30(4):848-52. PubMed ID: 25662809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAMS 3rd Utian Translational Science Symposium, October 2016, Orlando, Florida A conversation about hormone therapy: is there an appropriate dose, route, and duration of use?
    The North American Menopause Society (NAMS)
    Menopause; 2017 Nov; 24(11):1221-1235. PubMed ID: 28968302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey.
    Gass ML; Stuenkel CA; Utian WH; LaCroix A; Liu JH; Shifren JL;
    Menopause; 2015 Dec; 22(12):1276-84. PubMed ID: 26382314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances help understand and improve the safety of menopausal therapies.
    Mirkin S; Archer DF; Pickar JH; Komm BS
    Menopause; 2015 Mar; 22(3):351-60. PubMed ID: 25051290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.
    Genazzani AR; Schneider HP; Panay N; Nijland EA
    Gynecol Endocrinol; 2006 Jul; 22(7):369-75. PubMed ID: 16864146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen replacement in postmenopausal women.
    Sassarini J; Lumsden MA
    Age Ageing; 2015 Jul; 44(4):551-8. PubMed ID: 26070875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHI risks: any relevance to menopause management?
    Burger HG
    Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for the menopause in Central America: use, knowledge, perceptions and attitudes among urban living middle-aged women.
    Tserotas K; Hernandez L; Morera F; Pineda R; Chedraui P
    Gynecol Endocrinol; 2011 Jul; 27(7):504-11. PubMed ID: 20626238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.